Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
Share Market News
ASX 200 (ASX:XJO) midday update: Aristocrat hits record high, Flight Centre sinks
Share Gainers
Healius (ASX:HLS) share price jumps 7% following huge Q1 earnings growth
Healthcare Shares
Virtus Health (ASX:VRT) share price shrugs off latest acquisition hurdle
Dividend Investing
Here are 2 ASX dividend shares analysts rate highly
Broker Notes
Brokers name 2 ASX healthcare shares to buy
Dividend Investing
Top brokers name 3 ASX dividend shares to buy today
Broker Notes
Leading brokers name 3 ASX shares to buy today
Share Market News
5 things to watch on the ASX 200 on Monday
Healthcare Shares
Why analysts rate these ASX healthcare shares highly
Broker Notes
Top brokers name 3 ASX shares to buy today
Share Gainers
Here's why the Healius (ASX:HLS) share price is storming 5% higher today
Broker Notes
The latest ASX shares to be hit by a broker downgrade
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.
